mosapride

Known as: 4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide, Benzamide, 4-amino-5-chloro-2-ethoxy-N-((4-((4-fluorophenyl)methyl)-2-morpholinyl)methyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 
 

Topic mentions per year

Topic mentions per year

1993-2017
0102019932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND AND AIM A substantial number of patients with gastroesophageal reflux disease show symptomatic resistance to high-dose… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
BACKGROUND AND AIM Since its introduction, capsule endoscopy (CE) has made it possible to visualize the small intestine mucosa… (More)
Is this relevant?
2005
2005
BACKGROUND In functional gastrointestinal (GI) disorders including functional dyspepsia (FD) and irritable bowel syndrome (IBS… (More)
Is this relevant?
2005
2005
Mosapride citrate is a novel selective 5-HT4 receptor agonist. It facilitates acetylcholine release from the enteric cholinergic… (More)
Is this relevant?
2003
2003
OBJECTIVE To evaluate the efficiency of the 5-HT4 agonist and 5-HT3 antagonist mosapride, as compared with cisapride, on… (More)
Is this relevant?
2002
2002
BACKGROUND Prokinetic agents have shown variable efficacy in the treatment of functional dyspepsia. Mosapride is a new prokinetic… (More)
Is this relevant?
2002
2002
It is known that 5-HT(4) receptors in the colon of guinea pigs show a distribution similar to that in humans. Thus, we examined… (More)
Is this relevant?
2000
2000
The goals of the present study were to identify the enzyme responsible for metabolism of itopride hydrochloride (itopride) and to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
In the present study the electrophysiological characteristics and the proarrhythmic potential of cisapride and a structurally… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 7
Is this relevant?
1997
1997
Mosapride citrate is a new gastroprokinetic agent that enhances the upper GI motility by stimulating 5-hydroxytryptamine4 (5-HT4… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 7
  • figure 6
Is this relevant?